Edge Asset Management’s Pfizer PFE Stock Holding History

Edge Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$112M	Buy	3,454,681 +37,060	+1%	+$1.17M	0.85%	31
2016 Q4	$105M	Buy	3,417,621 +53,149	+2%	+$1.62M	0.81%	33
2016 Q3	$108M	Buy	3,364,472 +43,735	+1%	+$1.46M	0.91%	30
2016 Q2	$111M	Buy	3,320,737 +115,720	+4%	+$3.69M	0.99%	27
2016 Q1	$90.1M	Sell	3,205,017 -292,931	-8%	-$8.37M	0.86%	37
2015 Q4	$107M	Sell	3,497,948 -243,128	-6%	-$7.65M	1.04%	24
2015 Q3	$111M	Buy	3,741,076 +154,072	+4%	+$4.94M	1.11%	18
2015 Q2	$114M	Sell	3,587,004 -15,127	-0.4%	-$493K	1.03%	25
2015 Q1	$119M	Sell	3,602,131 -150,493	-4%	-$4.78M	1.03%	19
2014 Q4	$111M	Sell	3,752,624 -185,163	-5%	-$5.31M	1.07%	25
2014 Q3	$110M	Sell	3,937,787 -171,601	-4%	-$4.82M	1.11%	22
2014 Q2	$116M	Buy	4,109,388 +9,164	+0.2%	+$261K	1.16%	20
2014 Q1	$125M	Sell	4,100,224 -5,908	-0.1%	-$176K	1.32%	17
2013 Q4	$119M	Sell	4,106,132 -4,233,909	-51%	-$123M	1.3%	16
2013 Q3	$224M	Buy	8,340,041 +4,176,685	+100%	+$114M	1.37%	16
2013 Q2	$111M	Buy	+4,163,356	New	+$115M	1.39%	14

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Edge Asset Management's PFE Position: Q1 2017 in Review

Edge Asset Management increased its Pfizer (PFE) stake by 1.1% in Q1 2017, buying an estimated $1.17M and bringing the position to 3,454,681 shares worth $112M. The position accounts for 0.85% of the portfolio, ranked #31.

Edge Asset Management first reported a position in PFE in Q2 2013 and has held it in 16 quarters since. The position peaked at $224M in Q3 2013. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

Edge Asset Management held 3,454,681 shares of Pfizer worth $112M as of Q1 2017.
Edge Asset Management bought 37,060 Pfizer shares in Q1 2017, an estimated $1.17M.
Pfizer made up 0.85% of Edge Asset Management's portfolio in Q1 2017, its #31 holding.
Edge Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 16 quarters since.
Edge Asset Management's Pfizer position peaked at $224M in Q3 2013.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.